跳转至内容
Merck
CN
所有图片(1)

主要文件

查看所有文档

安全信息

49322

Sigma-Aldrich

NMP

puriss. p.a., ≥99.0% (GC)

别名:

N-甲基-2-吡咯烷酮, N-甲基吡咯烷酮, NMP

登录查看公司和协议定价
所有图片(1)

About This Item

经验公式（希尔记法）:
C5H9NO
CAS号:
872-50-4
分子量:
99.13
Beilstein:
106420
EC 号:
212-828-1
MDL编号:
MFCD00003193
UNSPSC代码:
12352005
PubChem化学物质编号:
329757410
方案:
≥99.0% (GC)
沸点:
202 °C (lit.)
81-82 °C/10 mmHg (lit.)
蒸汽压:
0.29 mmHg ( 20 °C)
0.99 mmHg ( 40 °C)

产品名称

1-甲基-2-吡咯烷酮, puriss. p.a., ≥99.0% (GC)

蒸汽密度

3.4 (vs air)

质量水平

100

蒸汽压

0.29 mmHg ( 20 °C)
0.99 mmHg ( 40 °C)

等级

puriss. p.a.

方案

≥99.0% (GC)

表单

liquid

自燃温度

518 °F

expl. lim.

9.5 %

杂质

≤0.1% water

折射率

n20/D 1.47 (lit.)
n20/D 1.470

pH值（酸碱度）

7.7-8

沸点

202 °C (lit.)
81-82 °C/10 mmHg (lit.)

mp

−24 °C (lit.)

密度

1.028 g/mL at 25 °C (lit.)

痕量阳离子

Ca: ≤5 mg/kg
Cd: ≤1 mg/kg
Co: ≤1 mg/kg
Cr: ≤1 mg/kg
Cu: ≤1 mg/kg
Fe: ≤1 mg/kg
K: ≤20 mg/kg
Mg: ≤1 mg/kg
Mn: ≤1 mg/kg
Na: ≤20 mg/kg
Ni: ≤1 mg/kg
Pb: ≤1 mg/kg
Zn: ≤1 mg/kg

SMILES字符串

CN1CCCC1=O

InChI

1S/C5H9NO/c1-6-4-2-3-5(6)7/h2-4H2,1H3

InChI key

SECXISVLQFMRJM-UHFFFAOYSA-N

正在寻找类似产品? 访问 产品对比指南

象形图

Health hazardExclamation mark
GHS08,GHS07

警示用语：

Danger

危险分类

Eye Irrit. 2 - Repr. 1B - Skin Irrit. 2 - STOT SE 3

靶器官

Respiratory system

储存分类代码

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

WGK

WGK 1

闪点(°F)

195.8 °F - Pensky-Martens closed cup

闪点(°C)

91 °C - Pensky-Martens closed cup

个人防护装备

Eyeshields, Gloves, type ABEK (EN14387) respirator filter

法规信息

新产品

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

抱歉，我们目前尚未线上提供该产品的COA。

如需帮助，请联系 客户支持

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

B A Jönsson et al.
Journal of chromatography. B, Biomedical sciences and applications, 694(2), 351-357 (1997-07-04)
A method for simultaneous determination of 5-hydroxy-N-methylpyrrolidone and 2-hydroxy-N-methylsuccinimide in urine is described. These compounds are metabolites of N-methyl-2-pyrrolidone, a powerful and widely used organic solvent. 5-Hydroxy-N-methylpyrrolidone and 2-hydroxy-N-methylsuccinimide were purified from urine by adsorption to a C8 solid-phase extraction
K J Brodbeck et al.
Journal of controlled release : official journal of the Controlled Release Society, 62(3), 333-344 (1999-10-21)
The role of solvent properties and bath-side composition on the phase inversion dynamics and in vitro protein release kinetics of polylactic-co-glycolic acid (PLGA) solutions has been examined using dark ground imaging, in vitro release rate, and SEM techniques. Thermodynamic phase
Ajit Dhananjay Jagtap et al.
European journal of medicinal chemistry, 85, 268-288 (2014-08-05)
A series of 6-acylureido derivatives containing a 3-(pyrrol-2-ylmethylidene)indolin-2-one scaffold were synthesized as potential dual Aurora B/FLT3 inhibitors by replacing the 6-arylureido moiety in 6-arylureidoindolin-2-one-based multi-kinase inhibitors. (Z)-N-(2-(pyrrolidin-1-yl)ethyl)-5-((6-(3-(2-fluoro-4-methoxybenzoyl)ureido)-2-oxoindolin-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide (54) was identified as a dual Aurora B/FLT3 inhibitor (IC50 = 0.4 nM and 0.5 nM, respectively).
Hsiao-Chun Wang et al.
European journal of medicinal chemistry, 84, 312-334 (2014-07-19)
Bioisosteric replacement of acylureido moiety in 6-acylureido-3-pyrrolylmethylidene-2-oxoindoline derivatives resulted in a series of malonamido derivatives with indolin-2-one scaffold (11-14). Further conformational restrictions of the malonamido moiety led to 2-oxo-1,2-dihydropyridine (21-25) or a 4-oxo-1,4-dihydropyridine derivatives (31-36). 4-Oxo-1,4-dihydropyridine derivatives were more potent
Yichao Wang et al.
Nano letters, 15(2), 883-890 (2015-01-07)
The exhibition of plasmon resonances in two-dimensional (2D) semiconductor compounds is desirable for many applications. Here, by electrochemically intercalating lithium into 2D molybdenum disulfide (MoS2) nanoflakes, plasmon resonances in the visible and near UV wavelength ranges are achieved. These plasmon
查看所有相关文献

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门